Cancer Screening During the COVID-19 Pandemic: A Systematic Review and Meta-analysis.

The purpose of this study was to assess the impact of measures designed to mitigate the spread of coronavirus disease 2019 (COVID-19) on worldwide cancer screening. We systematically searched PubMed, Ovid MEDLINE, the Cochrane COVID-19 Study Register, ClinicalTrials.gov, and EMBASE without language...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	MacKenzie Mayo, MD, Bindu Potugari, MD, Rami Bzeih, DO, Caleb Scheidel, MS, Carolyn Carrera, MD, Richard A. Shellenberger, DO
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/fc11ee3c3d404a7fab924fb48a7cfa76
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:fc11ee3c3d404a7fab924fb48a7cfa76
record_format	dspace
spelling	oai:doaj.org-article:fc11ee3c3d404a7fab924fb48a7cfa762021-11-28T04:36:13ZCancer Screening During the COVID-19 Pandemic: A Systematic Review and Meta-analysis.2542-454810.1016/j.mayocpiqo.2021.10.003https://doaj.org/article/fc11ee3c3d404a7fab924fb48a7cfa762021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2542454821001557https://doaj.org/toc/2542-4548The purpose of this study was to assess the impact of measures designed to mitigate the spread of coronavirus disease 2019 (COVID-19) on worldwide cancer screening. We systematically searched PubMed, Ovid MEDLINE, the Cochrane COVID-19 Study Register, ClinicalTrials.gov, and EMBASE without language restrictions for studies published between January 1, 2021, and February 10, 2021. Studies selected for full-text review contained data on patients screened for any type of cancer during the COVID-19 pandemic and comparison data from a time interval just prior to the pandemic. Data were obtained through dual extraction. All the included studies were assessed for quality and risk of bias. A meta-analysis was performed on 13 studies: 7 on screening mammography, 5 on colon cancer screening, and 3 on cervical cancer screening. Two of our studies reported on more than one type of cancer screening. The screening outcomes were reported as pooled incidence rate ratios using the inverse variance method and random effects models. All studies included in our meta-analysis reported the number of patients screened for cancer in defined time intervals before and during the COVID-19 pandemic. We found that the pooled incidence rate ratios were significantly lower for screening during the COVID-19 pandemic for breast cancer (0.63; 95% CI, 0.53 to 0.77; P<.001), colon cancer (0.11; 95% CI, 0.05 to 0.24; P<.001), and cervical cancer (0.10; 95% CI, 0.04 to 0.24; P<.001). These findings may add further morbidity and mortality to this public health crisis.MacKenzie Mayo, MDBindu Potugari, MDRami Bzeih, DOCaleb Scheidel, MSCarolyn Carrera, MDRichard A. Shellenberger, DOElsevierarticleMedicine (General)R5-920ENMayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 6, Pp 1109-1117 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine (General) R5-920
spellingShingle	Medicine (General) R5-920 MacKenzie Mayo, MD Bindu Potugari, MD Rami Bzeih, DO Caleb Scheidel, MS Carolyn Carrera, MD Richard A. Shellenberger, DO Cancer Screening During the COVID-19 Pandemic: A Systematic Review and Meta-analysis.
description	The purpose of this study was to assess the impact of measures designed to mitigate the spread of coronavirus disease 2019 (COVID-19) on worldwide cancer screening. We systematically searched PubMed, Ovid MEDLINE, the Cochrane COVID-19 Study Register, ClinicalTrials.gov, and EMBASE without language restrictions for studies published between January 1, 2021, and February 10, 2021. Studies selected for full-text review contained data on patients screened for any type of cancer during the COVID-19 pandemic and comparison data from a time interval just prior to the pandemic. Data were obtained through dual extraction. All the included studies were assessed for quality and risk of bias. A meta-analysis was performed on 13 studies: 7 on screening mammography, 5 on colon cancer screening, and 3 on cervical cancer screening. Two of our studies reported on more than one type of cancer screening. The screening outcomes were reported as pooled incidence rate ratios using the inverse variance method and random effects models. All studies included in our meta-analysis reported the number of patients screened for cancer in defined time intervals before and during the COVID-19 pandemic. We found that the pooled incidence rate ratios were significantly lower for screening during the COVID-19 pandemic for breast cancer (0.63; 95% CI, 0.53 to 0.77; P<.001), colon cancer (0.11; 95% CI, 0.05 to 0.24; P<.001), and cervical cancer (0.10; 95% CI, 0.04 to 0.24; P<.001). These findings may add further morbidity and mortality to this public health crisis.
format	article
author	MacKenzie Mayo, MD Bindu Potugari, MD Rami Bzeih, DO Caleb Scheidel, MS Carolyn Carrera, MD Richard A. Shellenberger, DO
author_facet	MacKenzie Mayo, MD Bindu Potugari, MD Rami Bzeih, DO Caleb Scheidel, MS Carolyn Carrera, MD Richard A. Shellenberger, DO
author_sort	MacKenzie Mayo, MD
title	Cancer Screening During the COVID-19 Pandemic: A Systematic Review and Meta-analysis.
title_short	Cancer Screening During the COVID-19 Pandemic: A Systematic Review and Meta-analysis.
title_full	Cancer Screening During the COVID-19 Pandemic: A Systematic Review and Meta-analysis.
title_fullStr	Cancer Screening During the COVID-19 Pandemic: A Systematic Review and Meta-analysis.
title_full_unstemmed	Cancer Screening During the COVID-19 Pandemic: A Systematic Review and Meta-analysis.
title_sort	cancer screening during the covid-19 pandemic: a systematic review and meta-analysis.
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/fc11ee3c3d404a7fab924fb48a7cfa76
work_keys_str_mv	AT mackenziemayomd cancerscreeningduringthecovid19pandemicasystematicreviewandmetaanalysis AT bindupotugarimd cancerscreeningduringthecovid19pandemicasystematicreviewandmetaanalysis AT ramibzeihdo cancerscreeningduringthecovid19pandemicasystematicreviewandmetaanalysis AT calebscheidelms cancerscreeningduringthecovid19pandemicasystematicreviewandmetaanalysis AT carolyncarreramd cancerscreeningduringthecovid19pandemicasystematicreviewandmetaanalysis AT richardashellenbergerdo cancerscreeningduringthecovid19pandemicasystematicreviewandmetaanalysis
_version_	1718408357382979584

Cancer Screening During the COVID-19 Pandemic: A Systematic Review and Meta-analysis.

Ejemplares similares